Tyler R. Call
No Rating Available
(Learn About Our Rating System)

Tyler R. Call, MD

Languages spoken: English

  • Dr. Call is the Medical Director of the operating rooms at both the Huntsman Cancer Hospital (HCH) and the Kathryn F. Kirk Center for Comprehensive Cancer Care and Women's Cancers (KFK). He also serves at the Director of Anesthesia Services at these sites. His clinical focus is on periopertive care of the cancer patient and the majority of his current research endevors are in collaboration with oncologic surgeons here at HCH and KFK.

    Specialties

    Board Certification

    American Board of Anesthesiology

  • Dr. Call is the Medical Director of the operating rooms at both the Huntsman Cancer Hospital (HCH) and the Kathryn F. Kirk Center for Comprehensive Cancer Care and Women's Cancers (KFK). He also serves at the Director of Anesthesia Services at these sites. His clinical focus is on periopertive care of the cancer patient and the majority of his current research endevors are in collaboration with oncologic surgeons here at HCH and KFK.

    Board Certification and Academic Information

    Academic Departments Anesthesiology -Primary
    Board Certification
    American Board of Anesthesiology

    Education history

    Fellowship Anesthesiology - Huntsman Cancer Hospital Clinical Research Fellow
    Residency Anesthesiology - University of Utah Resident
    Internship Transitional Year - St. Josephs Hospital in Syracuse New York Transitional Internship
    Professional Medical Medicine - State University of New York, Upstate Medical University M.D.
    Undergraduate University of Utah B.S.
    Undergraduate Brigham Young University Hawaii/Provo

    Selected Publications

    Journal Article

    1. Boesl MA, Brown N, Bleicher J, Call T, Lambert DH, Lambert LA (2024). Continuous Wound Irrigation and Intraoperative Methadone Decreases Opioid Use and Shortens Length of Stay After CRS/HIPEC. Ann Surg Oncol, 31(6), 3742-3749. (Read full article)
    2. Campsen J, Call T, Allen CM, Presson AP, Martinez E, Rofaiel G, Kim RD (2019). Prospective, double-blind, randomized clinical trial comparing an ERAS pathway with ketorolac and pregabalin versus standard of care plus placebo during live donor nephrectomy for kidney transplant. Am J Transplant, 19(6), 1777-1781. (Read full article)